148 related articles for article (PubMed ID: 36320663)
21. First Imported Case of SARS-CoV-2 Omicron Subvariant BA.4 - Guangdong Province, China, May 4, 2022.
Guo Q; Wu C; Deng A; Liang J; Zhao X; A R; Liu J; Ouyang F; Xu J; Huang S; Song Y; Zou L; Deng X; Nie K; Li B
China CDC Wkly; 2022 Oct; 4(40):902-903. PubMed ID: 36285320
[No Abstract] [Full Text] [Related]
22. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
[TBL] [Abstract][Full Text] [Related]
23. First Imported Case of SARS-CoV-2 Omicron Subvariant BA.2.12.1 - Guangdong Province, China, April 30, 2022.
Liang L; Zhao X; Deng A; Li K; Liu J; Ouyang F; Guo Q; Xu J; Huang S; Zou L; Song Y; Nie K; Li B
China CDC Wkly; 2022 Aug; 4(31):693-694. PubMed ID: 36059790
[No Abstract] [Full Text] [Related]
24. Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2.
Parums DV
Med Sci Monit; 2022 Jul; 28():e937676. PubMed ID: 35775166
[TBL] [Abstract][Full Text] [Related]
25. Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion.
Hossain A; Akter S; Rashid AA; Khair S; Alam ASMRU
Microb Pathog; 2022 Sep; 170():105699. PubMed ID: 35944840
[TBL] [Abstract][Full Text] [Related]
26. First Imported Case of SARS-CoV-2 Omicron Subvariant BA.5 - Shanghai Municipality, China, May 13, 2022.
Jiang H; Wu C; Xu W; Chen H; Fang F; Chen M; Wang C; Yuan L; Wu H; Teng Z; Guo J; Zheng Y; Lyu X; Qiao X; Wu G; Tan W; Zhang X
China CDC Wkly; 2022 Jul; 4(30):665-666. PubMed ID: 36062067
[No Abstract] [Full Text] [Related]
27. Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
Ngiam JN; Al-Mubaarak A; Maurer-Stroh S; Tambyah PA
Singapore Med J; 2022 Dec; ():. PubMed ID: 36648003
[TBL] [Abstract][Full Text] [Related]
28. Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein.
Javanmardi K; Segall-Shapiro TH; Chou CW; Boutz DR; Olsen RJ; Xie X; Xia H; Shi PY; Johnson CD; Annapareddy A; Weaver S; Musser JM; Ellington AD; Finkelstein IJ; Gollihar JD
Cell Host Microbe; 2022 Sep; 30(9):1242-1254.e6. PubMed ID: 35988543
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients.
Deng H; Mai Y; Liu H; Guan J
Ann Hepatol; 2023; 28(1):100763. PubMed ID: 36182032
[TBL] [Abstract][Full Text] [Related]
30. Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.
Wilhelm A; Widera M; Grikscheit K; Toptan T; Schenk B; Pallas C; Metzler M; Kohmer N; Hoehl S; Marschalek R; Herrmann E; Helfritz FA; Wolf T; Goetsch U; Ciesek S
EBioMedicine; 2022 Aug; 82():104158. PubMed ID: 35834885
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms responsible for SARS-CoV-2 antibody waning and vaccine escape in Omicron sublineages BA.4 and BA.5.
Hewins B; Richardson C; Rubino S; Kelvin A; Toloue Ostadgavahi A; Kelvin DJ
J Infect Dev Ctries; 2022 Jul; 16(7):1122-1125. PubMed ID: 35905015
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75.
Cao Y; Song W; Wang L; Liu P; Yue C; Jian F; Yu Y; Yisimayi A; Wang P; Wang Y; Zhu Q; Deng J; Fu W; Yu L; Zhang N; Wang J; Xiao T; An R; Wang J; Liu L; Yang S; Niu X; Gu Q; Shao F; Hao X; Meng B; Gupta RK; Jin R; Wang Y; Xie XS; Wang X
Cell Host Microbe; 2022 Nov; 30(11):1527-1539.e5. PubMed ID: 36270286
[TBL] [Abstract][Full Text] [Related]
33. Genomic Surveillance of SARS-CoV-2 in the Southern Province of Zambia: Detection and Characterization of Alpha, Beta, Delta, and Omicron Variants of Concern.
Katowa B; Kalonda A; Mubemba B; Matoba J; Shempela DM; Sikalima J; Kabungo B; Changula K; Chitanga S; Kasonde M; Kapona O; Kapata N; Musonda K; Monze M; Tembo J; Bates M; Zumla A; Sutcliffe CG; Kajihara M; Yamagishi J; Takada A; Sawa H; Chilengi R; Mukonka V; Muleya W; Simulundu E
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146671
[TBL] [Abstract][Full Text] [Related]
34. Real-world effectiveness of azvudine for patients infected with the SARS-CoV-2 omicron subvariant BA.5 in an intensive care unit.
Qi X; Yang Y; Gong B; Li Z; Liang D
J Thorac Dis; 2023 Sep; 15(9):4925-4937. PubMed ID: 37868850
[TBL] [Abstract][Full Text] [Related]
35. Case Report: Omicron BA.2 Subvariant of SARS-CoV-2 Outcompetes BA.1 in Two Co-infection Cases.
Gjorgjievska M; Mehandziska S; Stajkovska A; Pecioska-Dokuzovska S; Dimovska A; Durmish I; Ismail S; Pavlovska T; Stojchevska A; Amedi H; Andonova J; Nikolovska M; Velickovikj S; Mitrev Z; Kungulovski I; Kungulovski G
Front Genet; 2022; 13():892682. PubMed ID: 35495156
[TBL] [Abstract][Full Text] [Related]
36. Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau.
Xu C; Wang J; Yu L; Sui X; Wu Q
Front Public Health; 2022; 10():1029171. PubMed ID: 36703829
[TBL] [Abstract][Full Text] [Related]
37. Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants.
Qu P; Evans JP; Kurhade C; Zeng C; Zheng YM; Xu K; Shi PY; Xie X; Liu SL
bioRxiv; 2022 Oct; ():. PubMed ID: 36299433
[TBL] [Abstract][Full Text] [Related]
38. XBB.1.16 Omicron subvariant rise to a variant of interest: Implications for global alertness and preparedness.
John OO; Olabode ON; Lucero-Prisno Iii DE; Adebimpe OT; Singh A
J Taibah Univ Med Sci; 2023 Dec; 18(6):1285-1287. PubMed ID: 37250814
[TBL] [Abstract][Full Text] [Related]
39. Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3.
Huang M; Wu L; Zheng A; Xie Y; He Q; Rong X; Han P; Du P; Han P; Zhang Z; Zhao R; Jia Y; Li L; Bai B; Hu Z; Hu S; Niu S; Hu Y; Liu H; Liu B; Cui K; Li W; Zhao X; Liu K; Qi J; Wang Q; Gao GF
Immunity; 2022 Aug; 55(8):1501-1514.e3. PubMed ID: 35777362
[TBL] [Abstract][Full Text] [Related]
40. A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic.
Singh P; Negi SS; Bhargava A; Kolla VP; Arora RD
Arch Med Res; 2022 Sep; 53(6):574-584. PubMed ID: 36123226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
